Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Bianchi, Nicoletta ^a   Finotti, Alessia ^a   Ferracin, Manuela ^a   Lampronti, Ilaria ^a   Zuccato, Cristina ^a   Breveglieri, Giulia ^a   Brognara, Eleonora ^a   Fabbri, Enrica ^a   Borgatti, Monica ^a   Negrini, Massimo ^a   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GLOBIN MESSENGER RNA; GLYCOPHORIN A; HEMOGLOBIN F; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 210; MITHRAMYCIN; RAPAMYCIN; RAPTOR PROTEIN; S6 KINASE; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; HEMOGLOBIN GAMMA CHAIN; MICRORNA; MIRN210 MICRORNA, HUMAN; MTOR PROTEIN, HUMAN; RPTOR PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TARGET OF RAPAMYCIN KINASE;

3' UNTRANSLATED REGION; ADOLESCENT; ARTICLE; BETA THALASSEMIA; BINDING SITE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYB5R2 GENE; DOWN REGULATION; ENZYME PHOSPHORYLATION; FANK1 GENE; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RAPTOR GENE; RNA BINDING; UPREGULATION; BIOSYNTHESIS; DRUG EFFECTS; ERYTHROID CELL; GENETICS; K-562 CELL LINE; MALE; METABOLISM;

MAMMALIA; RAPTORES;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BETA-THALASSEMIA; CELL DIFFERENTIATION; ERYTHROID CELLS; FEMALE; GAMMA-GLOBINS; GENE EXPRESSION REGULATION; HUMANS; K562 CELLS; MALE; MICRORNAS; PLICAMYCIN; TOR SERINE-THREONINE KINASES;

EID: 84929500836     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121567     Document Type: Article

References (79)

1. Hager GL, McNally JG, Misteli T (2009) Transcription dynamics. Mol Cell 35: 741-753. doi: 10.1016/j. molcel.2009.09.005 PMID: 19782025
2. Wilton SD, Fletcher S (2005) RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes. Curr Gene Ther 5: 467-483. PMID: 16250888
3. Van Der Kelen K, Beyaert R, Inzé D, De Veylder L (2009) Translational control of eukaryotic gene expression. Crit Rev Biochem Mol Biol 44: 143-168. doi: 10.1080/10409230902882090 PMID: 19604130
4. Houseley J, Tollervey D (2009) The many pathways of RNA degradation. Cell 136: 763-776. doi: 10. 1016/j.cell.2009.01.019 PMID: 19239894
5. Sontheimer EJ, CarthewRW (2005) Silence from within: endogenous siRNAs and microRNAs. Cell 122: 9-12. PMID: 16009127
6. Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS (2005) Post-transcriptional gene silencing by siRNAs and microRNAs. Curr Opin Struct Biol 15: 331-341. PMID: 15925505
7. Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132: 4653-4662. PMID: 16224045
8. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531. PMID: 15211354
9. Lim L P, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773. PMID: 15685193
10. Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32(Database issue): D109-11. PMID: 14681370
11. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, et al. (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 102, 18081-18086. PMID: 16330772
12. Choong ML, Yang HH, McNiece I (2007) MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp Hematol 35: 551-564. PMID: 17379065
13. Georgantas RW 3rd, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, et al. (2007) CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 104: 2750-2755. PMID: 17293455
14. Chen CZ, Lodish HF (2005) MicroRNAs as regulators of mammalian hematopoiesi Semin Immunol 17: 155-165. PMID: 15737576
15. Kluiver J, Kroesen BJ, Poppema S, van den Berg A (2006) The role of microRNAs in normal hematopoiesis and hematopoietic malignancies. Leukemia 20: 1931-1936. PMID: 16990772
16. Masaki S, Ohtsuka R, Abe Y, Muta K, Umemura T (2007) Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem Biophys Res Comm 364: 509-514. PMID: 17964546
17. Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT (2007) Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 35: 1657-1667. PMID: 17976518
18. Spinello I, Quaranta MT, Pasquini L, Pelosi E, Petrucci E, Pagliuca A, et al. (2009) PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis. Oncogene 28: 2276-2288. doi: 10. 1038/onc.2009.87 PMID: 19421145
19. Lawrie CH (2007) MicroRNAs and haematology: small molecules, big function. Br J Haematol 137: 503-512. PMID: 17539773
20. Yang GH, Wang F, Yu J, Wang XS, Yuan JY, Zhang JW (2009) MicroRNAs are involved in erythroid differentiation control. J Cell Biochem 107: 548-556. doi: 10.1002/jcb.22156 PMID: 19350553
21. Felli N, Pedini F, Romania P, Biffoni M, Morsilli O, Castelli G, et al. (2009) MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 94: 479-486. doi: 10.3324/ haematol.2008.002345 PMID: 19278969
22. Dore LC, Amigo JD, dos Santos CO, Zhang Z, Gai X, Tobias JW, Yu D, et al. (2008) A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci USA 105: 3333-3338. doi: 10.1073/ pnas.0712312105 PMID: 18303114
23. Kosaka N, Sugiura K, Yamamoto Y, Yoshioka Y, Miyazaki H, Komatsu N, et al. (2008) Identification of erythropoietin-induced microRNAs in haematopoietic cells during erythroid differentiation. Br J Haematol 142: 293-300. doi: 10.1111/j.1365-2141.2008.07151.x PMID: 18492109
24. Bianchi N, Osti F, Rutigliano C, Ginanni Corradini F, Borsetti E, Tomassetti M, et al. (1999) The DNAbinding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells. Br J Haematol 104: 258-265. PMID: 10050705
25. Fibach E, Bianchi N, Borgatti M, Prus E, Gambari R (2003) Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Blood 102: 1276-1281. PMID: 12738678
26. Feriotto G, Salvatori F, Finotti A, Breveglieri G, Venturi M, Zuccato C, et al. (2008) A novel frameshift mutation (+A) at codon 18 of the beta-globin gene associated with high persistence of fetal hemoglobin phenotype and deltabeta-thalassemia. Acta Haematologica 119: 28-37. doi: 10.1159/000114204 PMID: 18230963
27. Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R (2009) Expression of microRNA-210 during erythroid differentiation and induction of gamma-globin gene expression. BMB reports 42: 493-499. PMID: 19712585
28. Krützfeldt J, Kuwajima S, Braich R, Rajeev KG, Pena J, Tuschl T, et al. (2007) Specificity, duplex degradation and subcellular localization of antagomicroRNAs. Nucleic Acids Res 35: 2885-2892. PMID: 17439965
29. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. (2005) Silencing of microRNAs in vivo with 'antagomicroRNAs'. Nature 438: 685-689. PMID: 16258535
30. Goyal BR, Patel MM, Soni MK, Bhadada SV (2009) Therapeutic opportunities of small interfering RNA. Fundam Clin Pharmacol 23: 367-386. Review doi: 10.1111/j.1472-8206.2009.00694.x PMID: 19709318
31. Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45: 321-334. PMID: 163658
32. Bianchi N, Chiarabelli C, Borgatti M, Mischiati C, Fibach E, Gambari R (2001) Accumulation of gammaglobin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine. Br J Haematol 113: 951-961. PMID: 11442489
33. Fibach E, Manor D, Oppenheim A, Rachmilewitz EA (1989) Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 73: 100-103. PMID: 2910352
34. Gambari R, Fibach E (2007) Medicinal chemistry of fetal hemoglobin inducers for treatment of betathalassemia. Curr Med Chem 14: 199-212. PMID: 17266579
35. Fibach E, Bianchi N, Borgatti M, Zuccato C, Finotti A, Lampronti I, et al. (2006) Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from betathalassaemia patients. Eur J Haematol 77: 437-441. PMID: 16939628
36. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254. PMID: 942051
37. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, et al. (2007) A microRNA signature of hypoxia. Mol Cell Biol 27: 1859-1867. PMID: 17194750
38. Ivan M, Harris AL, Martelli F, Kulshreshtha R (2008) Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med 12: 1426-1431. doi: 10.1111/j.1582-4934.2008.00398.x PMID: 18624759
39. Pulkkinen K, Malm T, Turunen M, Koistinaho J, Ylä-Herttuala S (2008) Hypoxia induces microRNA microRNA-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by microRNA-210. FEBS Lett 582: 2397-23401. doi: 10.1016/j.febslet.2008.05.048 PMID: 18539147
40. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, et al. (2008) Micro-RNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883. doi: 10.1074/jbc.M800731200 PMID: 18417479
41. Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, Kulshreshtha R, et al. (2009) An integrated approach for experimental target identification of hypoxia-induced microRNA-210. J Biol Chem 284: 35134-35143. doi: 10.1074/jbc.M109.052779 PMID: 19826008
42. He J, Wu J, Xu N, Xie W, Li M, Li J, et al. (2013) MicroRNA-210 disturbs mitotic progression through regulating a group of mitosis-related genes. Nucleic Acids Res 41: 498-508. doi: 10.1093/nar/gks995 PMID: 23125370
43. Fasanaro P, Romani S, Voellenkle C, Maimone B, Capogrossi MC, Martelli F (2012) ROD1 is a seedless target gene of hypoxia-induced microRNA-210. PLoS One 7: e44651. PMID: 23024754
44. Nakada C, Tsukamoto Y, Matsuura K, Nguyen TL, Hijiya N, Uchida T, et al. (2011) Overexpression of microRNA-210, a downstream target of HIF1alfa, causes centrosome amplification in renal carcinoma cells. J Pathol 224: 280-288. doi: 10.1002/path.2860 PMID: 21465485
45. Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N (1996) Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 15: 658-664. PMID: 8599949
46. Lawrence JC Jr, Abraham RT (1997) PHAS/4E-BPs as regulators of mRNA translation and cell proliferation. Trends Biochem Sci 22: 345-349. PMID: 9301335
47. Mischiati C, Sereni A, Lampronti I, Bianchi N, Borgatti M, Prus E, et al. (2004) Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells. Br J Haematol 126: 612-621. PMID: 15287957
48. Oshiro N, Yoshino K, Hidayat S, Tokunaga C, Hara K, Eguchi S, et al. (2004) Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells 9: 359-366. PMID: 15066126
49. Thomas G, Hall MN (1997) TOR signalling and control of cell growth. Curr Opin Cell Biol 9: 782-787. PMID: 9425342
50. Lane HA, Fernandez A, Lamb NJ, Thomas G (1993) p70s6k function is essential for G1 progression. Nature 363: 170-172. PMID: 8483501
51. Price DJ, Grove JR, Calvo V, Avruch J, Bierer BE (1992) Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257: 973-977. PMID: 1380182
52. Chung J, Kuo CJ, Crabtree GR, Blenis J (1992) Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69: 1227-1236. PMID: 1377606
53. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, et al. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110: 177-189. PMID: 12150926
54. Nojima H, Tokunaga C, Eguchi S, Oshiro N, Hidayat S, Yoshino K, et al. (2003) The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J Biol Chem 278: 15461-15464. PMID: 12604610
55. Schalm SS & Blenis J (2002) Identification of a conserved motif required for mTOR signaling. Curr Biol 12: 632-639. PMID: 11967149
56. Dufner A, Thomas G (1999) Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res 253: 100-109. PMID: 10579915
57. Gingras AC, Raught B, Sonenberg N (2004) mTOR signaling to translation. Curr Top Microbiol Immunol 279: 169-197. PMID: 14560958
58. Raught B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL, et al. (2004) Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 23: 1761-1769. PMID: 15071500
59. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M (2006) S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth Science 314: 467-471. PMID: 17053147
60. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, et al. (2009) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163-175.
61. Dada S, Demartines N, Dormond O (2008) mTORC2 regulates PGE2-mediated endothelial cell survival and migration. Bioch Bioph Res Comm 372: 875-879. doi: 10.1016/j.bbrc.2008.05.154 PMID: 18539142
62. Kawasome H, Papst P, Webb S, Keller GM, Johnson GL, Gelfand EW, et al. (1998) Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. Proc Natl Acad Sci USA 95: 5033-5038. PMID: 9560223
63. Caplen N, Parrish S, Imani F, Fire A, Morgan RA (2001) Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 98: 9742-9747. PMID: 11481446
64. Meister G, Landthaler M, Dorsett Y, Tuschl T (2004) Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10: 544-550. PMID: 14970398
65. Khvorova A, Reynolds A, Jayasena SD (2009) Functional siRNAs and microRNAs exhibit strand bias. Cell 115: 209-216.
66. Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, et al. (2011) Knockdown of microRNA-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Research 13:R2, doi: 10.1186/bcr2803 PMID: 21219636
67. Sun K, Wang W, Zeng JJ, Wu CT, Lei ST, Guo-xin Li GX (2011) MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma. Acta Pharmacologica Sinica 32: 375-384. doi: 10.1038/ aps.2010.206 PMID: 21278784
68. Song B, Wang C, Jie Liu Wang X, Lv L, Wei L, et al. (2010) MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res 29:29. doi: 10.1186/1756-9966-29-29 PMID: 20346171
69. Yu J, Wang F, Yang GH, Wang FL, Ma YN, Du ZW, et al. (2006) Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Bioch Bioph Res Comm 349: 59-68.
70. Wang Q, Huang Z, Xue H, Jin C, Ju XL, Han JD, et al. (2008) MicroRNA microRNA-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 111: 588-595. PMID: 17906079
71. Du TT, Fu YF, Dong M, Wang L, Fan HB, Chen Y, et al. (2009) Experimental validation and complexity of microRNA-mRNA target interaction during zebrafish primitive erythropoiesis. Bioch Bioph Res Comm 381: 688-693. doi: 10.1016/j.bbrc.2009.02.122 PMID: 19254693
72. Corn PG (2008) Hypoxic regulation of microRNA-210: shrinking targets expand HIF-1's influence. Cancer Biol Ther 7: 265-267. PMID: 18347426
73. Noman MZ, Buart S, Romero P, Ketari S, Janji B, Mari B, et al. (2012) Hypoxia-inducible microRNA-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Cancer Res 72: 4929-4941.
74. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, et al. (2008) hsa-microRNA-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348. doi: 10.1158/1078-0432.CCR-07-1755 PMID: 18316553
75. Sarakul O, Vattanaviboon P, Tanaka Y, Fucharoen S, Abe Y, Svasti S, Umemura T. (2013) Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210. Blood Cells Mol Dis 51(2): 98-103. doi: 10.1016/j.bcmd.2013.03.005 PMID: 23623309
76. Narayan AD, Ersek A, Campbell TA, Colon DM, Pixley JS, Zanjani ED (2005) The effect of hypoxia and stem cell source on haemoglobin switching. Br J Haematol 128: 562-570. PMID: 15686468
77. Rogers HM., Yu X, Wen J, Smith R, Fibach E, Noguch CT (2008) Hypoxia alters progression of the erythroid program. Exp Hematol 36: 17-27. PMID: 17936496
78. Lin CJ, Sukarieh R, Pelletier J (2009) Silibinin inhibits translation initiation: implications for anticancer therapy. Mol Cancer Ther 8: 1606-1612. doi: 10.1158/1535-7163.MCT-08-1152 PMID: 19509268
79. Dudkin L, Dilling MB, Cheshire PJ, Harwood FC, Hollingshead M, Arbuck SG, et al. (2001) Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition. Clin Cancer Res 7: 1758-1764. PMID: 11410517